ORKA Earnings Oruka Therapeutics, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–21 of 21
| Q2 2025 | 2025-06-30 | -0.46 | 2025-08-11 | 10-Q |
| Q1 2025 | 2025-03-31 | -0.40 | 2025-05-14 | 10-Q |
| Q3 2024 | 2024-09-30 | -1.46 | 2024-11-13 | 10-Q |
| Q2 2024 | 2024-06-30 | -6.96 | 2024-08-01 | 10-Q |
| Q1 2024 | 2024-03-31 | -0.14 | 2024-04-25 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | -0.08 | 2024-02-01 | 10-K |
| FY 2023 | 2023-12-31 | -0.37 | 2024-02-01 | 10-K |
| Q3 2023 | 2023-09-30 | -0.10 | 2023-10-18 | 10-Q |
| Q1 2023 | 2023-06-30 | -0.10 | 2023-07-21 | 10-Q |
| Q1 2023 | 2023-03-31 | -0.09 | 2023-04-24 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | -0.08 | 2023-02-24 | 10-K |
| FY 2022 | 2022-12-31 | -0.69 | 2023-02-24 | 10-K |
| Q3 2022 | 2022-09-30 | -0.16 | 2022-10-28 | 10-Q |
| Q2 2022 | 2022-06-30 | -0.22 | 2022-08-02 | 10-Q |
| Q1 2022 | 2022-03-31 | -0.23 | — | — |
| FY 2021 | 2021-12-31 | -1.39 | — | — |
| Q3 2021 | 2021-09-30 | -0.33 | — | — |
| Q2 2021 | 2021-06-30 | -0.34 | — | — |
| Q2 2012 | 2012-06-30 | -0.09 | 2012-08-13 | 10-Q |
| Q2 2011 | 2011-06-30 | 0.03 | 2011-08-15 | 10-Q |
| Q2 2010 | 2010-06-30 | -0.26 | — | — |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.